is glp 1 bad for kidneys GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Design and discovery of a

This article explains how the medication creates weight loss independent of willpower alone

An update on immune-based alpha-synuclein trials in Parkinsons disease

[00:02:20] Emily Field: Because ultimately, the goal isnt just to become smaller, the goal is to become leaner, stronger, and healthier for the long term

Providing you with groundbreaking information rodents and humans are a little different

According to data presented at the AASLD Liver Meeting in November 2024, semaglutide has shown significant efficacy in managing liver inflammation and fibrosis in a phase III clinical trial

Mechanisms That Impact Cancer Risk with Use of Incretin Mimetics